Clover Health Investments, Corp. — Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, filed May 25, 2022, reports the planned appointment of Scott J. Leffler as Clover Health’s Chief Financial Officer, principal financial officer, and principal accounting officer. The appointment is expected to become effective when he begins employment in August 2022.
Financial Metrics and Liquidity
The filing is limited to an executive appointment and related compensation arrangements. It does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating or financial-period metrics.
Material Changes Compared with the Prior Comparable Period
- Scott J. Leffler will succeed Mark C. Herbers, who was serving as Interim Chief Financial Officer.
- Mr. Herbers will remain interim CFO until Mr. Leffler starts and will assist with the transition thereafter.
- Mr. Leffler previously served as CFO and Treasurer of Sotera Health since April 2017 and has held prior finance leadership roles at Exal Corporation and PolyOne Corporation.
Compensation, Outlook, Risks, and Unusual Items
- Annual base salary: $500,000.
- Initial target annual cash incentive: 75% of base salary.
- One-time restricted stock unit grant with a stated grant-date fair value of $12.0 million. Twenty-five percent vests on the first anniversary of the start date, with the remainder vesting in twelve equal quarterly installments beginning three months later, subject to continued service.
- One-time cash signing bonus: $100,000, payable in two equal installments. Repayment is required for certain voluntary terminations or terminations for cause within twelve months of the start date.
- Mr. Leffler is expected to enter into the Company’s standard executive indemnification agreement, including potential indemnification and advancement of defense expenses.
- The full employment agreement is expected to be filed with Clover Health’s Form 10-Q for the quarter ending June 30, 2022.
Key Facts for Investors to Verify
- Confirm the actual date Mr. Leffler commenced employment and formally assumed the CFO, principal financial officer, and principal accounting officer roles.
- Review the complete employment agreement and final RSU award documentation when filed.
- Assess the financial statement impact of the $12.0 million equity award, including recognized stock-based compensation and vesting conditions.
- Monitor the transition from the interim CFO and any subsequent changes in finance leadership or reporting controls.
- This filing does not provide updated financial results, guidance, liquidity information, or quantitative outlook; investors should consult subsequent periodic filings for those items.